Fig. 2: Clinical course and treatment timeline for Patient No. 2.

BX biopsy, G3 grade 3, ICT Department of Investigational Cancer Therapeutics, mo months, NED no evidence of disease, Tx treatment. Chromogranin A reference range ≤3.8 ng/mL.